Fig. 1

Association between ROR2 mRNA/protein expression level and clinicopathological parameters in the ICGC-PACA-AU,TCGA-PAAD and CPTAC-PDAC cohorts. A. No significant difference in ROR2 expression was observed between low and high tumour grade. B. ROR2 mRNA expression was not associated with stage, ROR2 protein expression was significantly different between low and high stage (p = 0.010). C. High ROR2 mRNA expression level was associated with better overall survival (p = 0.023) in the ICGC-PACA-AU cohort. D. High ROR2 mRNA expression level was associated with better overall survival (p = 0.008) in the TCGA-PAAD cohort. E. ROR2 mRNA was not associated with overall survival in the CPTAC-PDAC cohort. F. ROR2 protein was not associate with overall survival in the CPTAC-PDAC cohort.*Significance at p < 0.05 level